AJR Am J Roentgenol

1. 
   Correction for: "LI-RADS Ultrasound Surveillance Version 2024: Comparison With Version 2017 for Hepatocellular Carcinoma Detection and Risk Factors for Visualization Score C".
   AJR Am J Roentgenol. 2026 Mar 25:1. doi: 10.2214/AJR.25.34490.
   

   >> Share

   
   

   
   Am J Gastroenterol

2. JOHNSON PJ, Kalyuzhnyy A, Grauslys A, Toyoda H, et al
   Predicting the Risk of Decompensation in Patients with Cirrhosis - a Validated Machine Learning Approach.
   Am J Gastroenterol. 2026 Mar 25. doi: 10.14309/ajg.0000000000004004.
   

   >> Share

   
   

   
   Am J Pathol

3. ZHANG J, Zhou J, Shen X, Li Y, et al
   Cuproptosis Is Induced in Drug-Induced Liver Injury by Oxidative Stress-Mediated Copper Overload.
   Am J Pathol. 2026;196:868-882.
   

   >> Share

   
   
4. LIANG C, Chen X, Wang X, Tang J, et al
   Gpat3 knockout attenuates adipose loss and steatohepatitis in Agpat2-deficient mice.
   Am J Pathol. 2026 Mar 23:S0002-9440(26)00069.
   

   >> Share

   
   
5. CHEN H, Yang M, Tu X, Li J, et al
   Notch1-Gli1 axis reprograms macrophage polarization and promotes hepatic inflammation and fibrosis in metabolic dysfunction-associated steatohepatitis.
   Am J Pathol. 2026 Mar 19:S0002-9440(26)00063.
   

   >> Share

   
   

   
   Biochem Biophys Res Commun

6. YE F, Sun Y, Pan J
   Purpurogallin improves septic coagulopathy and hepatic injury through inhibiting AKT/mTOR/STAT3 signaling pathway.
   Biochem Biophys Res Commun. 2026;814:153669.
   

   >> Share

   
   

   
   BMC Cancer

7. DE MOURA ACC, Rizzo A, Santos TAB, Olivato GB, et al
   Efficacy and safety of immune-based combinations in metastatic hepatocellular carcinoma: a systematic review and network meta-analysis.
   BMC Cancer. 2026 Mar 25. doi: 10.1186/s12885-026-15893.
   

   >> Share

   
   
8. CHANG PY, Chiou WR
   Efficiency and safety of a guidewire-less approach to superselective transarterial microcatheter procedures in hepatic cancer interventions.
   BMC Cancer. 2026 Mar 25. doi: 10.1186/s12885-026-15907.
   

   >> Share

   
   

   
   BMC Gastroenterol

9. SARTINI C, Herrera R, Mazhar F, Torres ZA, et al
   Metabolic dysfunction-associated steatohepatitis in the real world: clinical burden, disease progression, and risk stratification with non-invasive tests.
   BMC Gastroenterol. 2026 Mar 26. doi: 10.1186/s12876-026-04745.
   

   >> Share

   
   

   
   Cancer Res

10. HAN L, Huo Y, Yang Y, Zhang L, et al
    The tRNA-Derived Fragment tRF-E Promotes Ferroptosis in Hepatocellular Carcinoma to Suppress Tumor Progression.
    Cancer Res. 2026 Mar 26. doi: 10.1158/0008-5472.CAN-25-2492.
    

    >> Share

    
    

    
    Eur J Pediatr

11. YIN T, Liu W, Chen X, Chen S, et al
    Pathological analysis of liver and cyst wall in prenatally diagnosed choledochal cysts in children.
    Eur J Pediatr. 2026;185:214.
    

    >> Share

    
    

    
    Gastroenterology

12. TAO X, Jiang W, Tang H
    A Mysterious Case of Diffuse Severe Hepatic Steatosis in a Thin Teenager.
    Gastroenterology. 2026 Mar 23:S0016-5085(26)00255.
    

    >> Share

    
    
13. MULLISH BH, Mullish BH
    Efimosfermin, a fibroblast growth factor 21 analogue, for metabolic dysfunction-associated steatohepatitis.
    Gastroenterology. 2026 Mar 23:S0016-5085(26)00256.
    

    >> Share

    
    
14. LOOMBA R, Clark VC, Mandorfer M, Miravitlles M, et al
    Multi-Society Expert Panel Consensus Guidance Regarding Clinical Assessment and Clinical Trial Endpoints in Adults With Alpha-1 Antitrypsin Deficiency-Associated Liver Disease.
    Gastroenterology. 2026;170:829-842.
    

    >> Share

    
    
15. TORP N, Johansen S, Jensen EL, Maagaard M, et al
    Prognostic Performance of Phosphatidylethanol With Noninvasive Liver Fibrosis Tests in Alcohol-Related Liver Disease.
    Gastroenterology. 2026;170:803-814.
    

    >> Share

    
    
16. CARTER JA, Dickerson LK, Stephanou A, Damle SR, et al
    Overcoming CXCR4-Mediated T-Cell Exclusion Potentiates Antitumor Cytotoxicity in Fibrolamellar Carcinoma.
    Gastroenterology. 2026;170:787-802.
    

    >> Share

    
    

    
    Hepatology

17. LIANG Z, Jin H, Gao W, Hu X, et al
    Prospective head-to-head comparison of routine non-invasive scores for predicting severe cirrhosis-related morbidity in the general population.
    Hepatology. 2026 Mar 23. doi: 10.1097/HEP.0000000000001749.
    

    >> Share

    
    

    
    Indian J Gastroenterol

18. BISWAS S, Madhusudhan KS, Shalimar
    Challenges in the management of vascular liver disorders in women in the reproductive period.
    Indian J Gastroenterol. 2026;45:178-191.
    

    >> Share

    
    
19. KOSUTA I, Kozina L, Cizmic P, Kosuta L, et al
    Non-invasive liver fibrosis screening and referral patterns in women with dependence due to psychoactive substance use: A single-centre retrospective study.
    Indian J Gastroenterol. 2026;45:259-267.
    

    >> Share

    
    
20. PENMETSA R, Kapil S, VanWagner LB
    Sex and gender differences in metabolic dysfunction-associated liver disease.
    Indian J Gastroenterol. 2026;45:192-201.
    

    >> Share

    
    
21. GOVALAN R, Singh S, Sharma P
    Gender disparities in liver transplantation.
    Indian J Gastroenterol. 2026;45:202-210.
    

    >> Share

    
    

    
    J Gastroenterol

22. ZHANG F, Wang YS, Liu LX, Wang JZ, et al
    Reply to "Checking the shape of hepatocellular carcinoma: How irregular is irregular?".
    J Gastroenterol. 2026 Mar 21. doi: 10.1007/s00535-026-02394.
    

    >> Share

    
    
23. ONO A, Miura R, Hayes CN, Kawaoka T, et al
    Reply to "IL-6 as a biomarker in atezolizumab plus bevacizumab in patients with hepatocellular carcinoma".
    J Gastroenterol. 2026 Mar 25. doi: 10.1007/s00535-026-02390.
    

    >> Share

    
    

    
    J Gastroenterol Hepatol

24. CHAN LL, Chan KOK, Chan SL
    Systemic Therapy for Advanced Hepatocellular Carcinoma in 2026: Current Standard-of-Care and Emerging Therapeutic Strategies.
    J Gastroenterol Hepatol. 2026 Mar 26. doi: 10.1111/jgh.70354.
    

    >> Share

    
    
25. WU F, Guo Z, Guan J, Xu J, et al
    IL-15 Plus Thymosin alpha1 Reduces Senescent Hepatic CD8(+) T Cells in Hepatocellular Carcinoma via PI3K/AKT Suppression.
    J Gastroenterol Hepatol. 2026 Mar 26. doi: 10.1111/jgh.70359.
    

    >> Share

    
    
26. KIM MN
    Reply Letter to: A Critical Assessment of "Aspirin Use and Risk of HCC and Gastrointestinal Bleeding in Patients With HBV-Related Cirrhosis: A Landmark Analysis".
    J Gastroenterol Hepatol. 2026 Mar 25. doi: 10.1111/jgh.70335.
    

    >> Share

    
    
27. KHAN T, Rizvi AR, Ahmad R, Saqib HW, et al
    Enhancing Prognostication in Hepatocellular Carcinoma Treated With Transarterial Chemoembolization: Beyond Baseline ALBI Grade.
    J Gastroenterol Hepatol. 2026 Mar 22. doi: 10.1111/jgh.70355.
    

    >> Share

    
    

    
    J Hepatol

28. WOLF C, Lange K, Stallmach A, Tannapfel A, et al
    Corrigendum to: "A rare vascular puzzle: Portal hypertension and hepatic lesions" [J Hepatol (2026) 84: e59-61].
    J Hepatol. 2026 Mar 25:S0168-8278(26)00125-X. doi: 10.1016/j.jhep.2026.
    

    >> Share

    
    
29. BALLESTER MP, Gallego-Duran R, Shalimar, Thomsen KL, et al
    Ammonia measurement in cirrhosis: International Delphi consensus recommendations from ISHEN.
    J Hepatol. 2026 Mar 20:S0168-8278(26)00146-7. doi: 10.1016/j.jhep.2026.
    

    >> Share

    
    

    
    N Engl J Med

30. 
    Tirzepatide for Metabolic Dysfunction-Associated Steatohepatitis with Liver Fibrosis.
    N Engl J Med. 2026;394:1248.
    

    >> Share

    
    

    
    Oncogene

31. DENG R, Zheng X, Liu F, Gao J, et al
    The NPC1/USP7/p53 axis regulates cholesterol and promotes the proliferation of hepatocellular carcinoma.
    Oncogene. 2026 Mar 26. doi: 10.1038/s41388-026-03739.
    

    >> Share

    
    

    
    PLoS One

32. KOSITAMONGKOL C, Tantiyavarong P, Ratanatawan A, Sripongpun P, et al
    Cost-utility and budget impact analyses of significant fibrosis detection in individuals with metabolic syndrome or obesity in Thailand.
    PLoS One. 2026;21:e0344985.
    

    >> Share

    
    
33. FUDEYASU K, Asaeda M, Kawae T, Nomura T, et al
    Association between diabetes mellitus and impaired single-leg stance in patients with chronic liver disease: A cross-sectional study.
    PLoS One. 2026;21:e0345407.
    

    >> Share

    
    
34. RADHA R, Anjum S, Abusamra RH, Paul V, et al
    Ultrasound-triggered doxorubicin targeted delivery for liver cancer treatment: Reduced toxicity and improved efficacy.
    PLoS One. 2026;21:e0345161.
    

    >> Share

    
    

    
    Radiology

35. CENTNER CS, Choi R, Georgiades CS, Yarchoan M, et al
    Thermal and Nonthermal Liver Ablation: Mechanistic Foundations, Clinical Implementation, Immunologic Trial Design, and Artificial Intelligence.
    Radiology. 2026;318:e250263.
    

    >> Share

    
    
36. DIMOPOULOS MP, Sotirchos VS, Vakiani E, Sigel C, et al
    Optimizing Colorectal Liver Metastasis Ablation through Metabolic Imaging, Margin Assessment, and Biopsy (The OPTABLATE Prospective Trial).
    Radiology. 2026;318:e250864.
    

    >> Share

    
    
37. DOPPELT G, Occean BV, Fabbro-Peray P, Haefliger L, et al
    The Safety Standards for Liver Percutaneous Thermal Ablation: A Meta-Analysis of Adverse Events over 15 Years.
    Radiology. 2026;318:e251517.
    

    >> Share

    
    

    
    Semin Liver Dis

38. SU F, Torres-Hernandez A, Hickey R, Shanbhogue K, et al
    Expert Practical Recommendations for Hepatocellular Carcinoma.
    Semin Liver Dis. 2026 Mar 25. doi: 10.1055/a-2832-4720.
    

    >> Share

    
    

    
    Transplant Proc

39. CHEN H, Zhang H, Guo S, Li J, et al
    Prolonged Prothrombin Time: A Reliable Clinical Indicator of Therapeutic Efficacy for Chronic Liver Failure Treated With Artificial Liver Support System.
    Transplant Proc. 2026;58:520-525.
    

    >> Share

    
    
40. LAREDO JA, Konakalla P, Khalil M, Helmick RA, et al
    Fixed Versus Growth Mindset and the Association With Alcohol Relapse After Liver Transplantation.
    Transplant Proc. 2026 Feb 26:S0041-1345(26)00087.
    

    >> Share

    
    
41. CHEN C, Zheng Q, Zhang L, Guo Q, et al
    Peptide Receptor Radionuclide Therapy for Recurrent Neuroendocrine Tumor Liver Metastases After Liver transplantation: A Case Series.
    Transplant Proc. 2026 Feb 26:S0041-1345(26)00100.
    

    >> Share

    
    

    
    Transplantation

42. MENG Q, Chen H, Li J, Qin M, et al
    Ischemia-free Liver Transplantation: 7-y Experience From a Single-center Cohort in China.
    Transplantation. 2025 Dec 2. doi: 10.1097/TP.0000000000005555.
    

    >> Share

    
    
43. NAKAYAMA T, Esquivel CO, Melcher ML, Sasaki K, et al
    Survival Benefit of Accepting Livers From Donation After Circulatory Death Donors Older Than or Equal to 60 y in the United States.
    Transplantation. 2026;110:e856-e865.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share